comparemela.com

16.02.2024 - Scholar Rock (NASDAQ: SRRK; “The Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play ...

Related Keywords

Lang Schwarz ,Twitter ,Linkedin ,Exchange Commission ,Scholar Rock Inc ,Scholar Rock Holding Registered Stock ,Scholar Rock ,Nasdaq Listing Rule ,Stock Option Award ,Securities Act ,Scholar Rock Holding Registered Chart ,Cholar Rock Holding Registered Kurs ,Cholar Rock Holding Registered Aktie ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.